Clinical Trial Update: A One-year, Open-label Study to Assess the Safety and Effectiveness of Extended Release Tramadol HCl in the Treatment of Chronic, Non-malignant Pain. [Phase 3]

View source ↗

Summary

This document reports the completion of a one-year, open-label Phase 3 study evaluating the safety and effectiveness of extended-release tramadol hydrochloride …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Extended Release Tramadol HCl (tramadol hydrochloride, extended-release)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Chronic Pain | Phase 3 | Status: COMPLETED